|Articles|October 11, 2018
Cancer Research Center Signs Multiyear Commitment to OmniComm’s TrialMaster EDC
Advertisement
A clinical research center signs a $3.5 Million commitment to TrialMaster EDC and OmniComm Systems, Inc., a global provider of clinical data management technology in hopes to use TrialMaster EDC for clinical data collection to develop patient-centric cancer therapies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
4
Reframing the IND: From Tactical Requirement to Strategic Opportunity
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
